Judge Ana Reyes orders the administration to explain discrepancies between new testosterone screening and the transgender military ban

Judge Ana Reyes has ordered the administration to provide a formal explanation regarding the discrepancy between the Pentagon's new testosterone screening program and its ongoing ban on transgender troops. The federal judge questioned why the military is promoting testosterone replacement therapy for cisgender soldiers while simultaneously arguing that the need for hormone treatment disqualifies transgender service members from active duty. Defense Secretary Pete Hegseth recently announced that all active-duty and reserve service members aged 30 and older will undergo annual screenings for testosterone deficiency. While Hegseth stated the goal is to maintain "maximum psychological and mental readiness," several medical experts expressed concern that blanket testing may lead to unnecessary treatment. Some doctors warned that inappropriate hormone replacement could negatively impact fertility and long-term health. The administration must now clarify its basis for treating trans men and cisgender soldiers differently before the next hearing on August 7. This ruling comes as the Pentagon continues to navigate lawsuits regarding the fitness and cost of gender-affirming care in the armed forces.

Sources